Kelly Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,515
| Closed | -$12.9K | – | 736 |
|
|
2022
Q4 | $12.9K | Hold |
14,515
| – | – | 0.01% | 308 |
|
|
2022
Q3 | $22.8K | Buy |
14,515
+7,150
| +97% | +$11.2K | 0.01% | 240 |
|
|
2022
Q2 | $14.8K | Hold |
7,365
| – | – | 0.01% | 281 |
|
|
2022
Q1 | $17.2K | Buy |
7,365
+3,365
| +84% | +$7.84K | 0.01% | 284 |
|
|
2021
Q4 | $18.6K | Hold |
4,000
| – | – | 0.01% | 276 |
|
|
2021
Q3 | $30.5K | Sell |
4,000
-34,760
| -90% | -$265K | 0.02% | 217 |
|
|
2021
Q2 | $4M | Buy |
38,760
+36,608
| +1,701% | +$3.78M | 0.15% | 39 |
|
|
2021
Q1 | $17.8K | Buy |
2,152
+1,000
| +87% | +$8.27K | 0.01% | 235 |
|
|
2020
Q4 | $7.86K | Hold |
1,152
| – | – | 0.01% | 309 |
|
|
2020
Q3 | $12.8K | Buy |
+1,152
| New | +$12.8K | 0.01% | 225 |
|